Detalhe da pesquisa
1.
Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors.
Eur J Clin Pharmacol
; 71(6): 663-672, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25939707
2.
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients.
Eur J Cancer
; 127: 52-66, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31986450
3.
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Eur J Cancer
; 136: 116-129, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688206
4.
Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis.
Blood Adv
; 2(4): 444-453, 2018 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29487059
5.
Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.
N Engl J Med
; 348(11): 994-1004, 2003 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637609
6.
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
N Engl J Med
; 346(9): 645-52, 2002 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-11870241
7.
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.
N Engl J Med
; 347(7): 472-80, 2002 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12181401
8.
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Clin Cancer Res
; 12(16): 4899-907, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16914578
9.
Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.
Nat Rev Drug Discov
; 1(7): 493-502, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12120256
10.
Implementation of mechanism of action biology-driven early drug development for children with cancer.
Eur J Cancer
; 62: 124-31, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27258969
11.
Pharmacokinetics and pharmacodynamics of imatinib in a phase I trial with chronic myeloid leukemia patients.
J Clin Oncol
; 22(5): 935-42, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14990650
12.
Pharmacogenomic analysis of cytogenetic response in chronic myeloid leukemia patients treated with imatinib.
Clin Cancer Res
; 10(1 Pt 1): 155-65, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14734464
13.
Correlation of major cytogenetic response with a pharmacogenetic marker in chronic myeloid leukemia patients treated with imatinib (STI571).
Clin Cancer Res
; 10(7): 2265-71, 2004 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15073101
14.
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study.
Clin Cancer Res
; 10(4): 1299-305, 2004 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14977828
15.
A phase I and pharmacokinetic study of SAM486A, a novel polyamine biosynthesis inhibitor, administered on a daily-times-five every-three-week schedule in patients with Advanced solid malignancies.
Clin Cancer Res
; 8(7): 2157-66, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114416
16.
Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.
Clin Cancer Res
; 8(7): 2167-76, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114417
17.
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Clin Cancer Res
; 8(7): 2177-87, 2002 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12114418
18.
Imatinib: a targeted clinical drug development.
Semin Hematol
; 40(2 Suppl 2): 15-20, 2003 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-12783370
19.
Imatinib: the first 3 years.
Eur J Cancer
; 38 Suppl 5: S77-82, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12528777
20.
Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.
J Clin Pharmacol
; 44(2): 158-62, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14747424